Drugs / M834
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02923583 | Oct 2016 → Jul 2017 | — | Momenta Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M834 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02923583 ↗ |
| Modality | Protein / enzyme biologic | “Biological: M834” NCT02923583 ↗ |